勘误：抗纤维化药物在新冠后间质性肺疾病管理中的作用：文献综述及专家工作组报告
Erratum: Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group.
出版信息
Lung India. 2022 May-Jun;39(3):310. doi: 10.4103/0970-2113.343593.
Abstract
[This corrects the article DOI: 10.4103/lungindia.lungindia_659_21].
摘要
[本文更正了文章的数字对象标识符：10.4103/lungindia.lungindia_659_21]。
相似文献
1
Erratum: Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group.勘误：抗纤维化药物在新冠后间质性肺疾病管理中的作用：文献综述及专家工作组报告
Lung India. 2022 May-Jun;39(3):310. doi: 10.4103/0970-2113.343593.
2
Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group.抗纤维化药物在新冠后间质性肺病管理中的作用：文献综述及专家工作组报告
Lung India. 2022 Mar-Apr;39(2):177-186. doi: 10.4103/lungindia.lungindia_659_21.
3
Erratum: Meropenem: A possible new culprit in eosinophilic lung diseases.勘误：美罗培南：嗜酸性粒细胞性肺病的一个可能新病因。
Lung India. 2017 Nov-Dec;34(6):581. doi: 10.4103/0970-2113.217583.
4
Erratum: Demographic comparison of the first, second and third waves of COVID-19 in a tertiary care hospital at Jaipur, India.勘误：印度斋浦尔一家三级护理医院中新冠疫情第一波、第二波和第三波的人口统计学比较。
Lung India. 2023 Jan-Feb;40(1):98. doi: 10.4103/0970-2113.365497.
5
Erratum: How a mild influenza B infection can kill: A case of pulmonary hemorrhage.勘误：轻度乙型流感感染何以致死：一例肺出血病例
Lung India. 2017 Nov-Dec;34(6):582. doi: 10.4103/0970-2113.217584.
6
Retraction: A review of convalescent plasma transfusion in COVID-19: Old wine reserved for special occasions.撤稿：关于COVID-19康复期血浆输注的综述：留作特殊场合的陈酿
Lung India. 2021 Jan-Feb;38(1):105. doi: 10.4103/0970-2113.306029.
7
Erratum: Medicine, Volume 95, Issue 23: Erratum.勘误：《医学》，第95卷，第23期：勘误。
Medicine (Baltimore). 2016 Jul 18;95(28):e0916. doi: 10.1097/01.md.0000489580.04709.16. eCollection 2016 Jul.
8
Erratum: Medicine, Volume 95, Issue 24: Erratum.勘误：《医学》，第95卷，第24期：勘误。
Medicine (Baltimore). 2016 Aug 7;95(31):e5074. doi: 10.1097/01.md.0000490009.39850.74. eCollection 2016 Aug.
9
Possible value of antifibrotic drugs in patients with progressive fibrosing non-IPF interstitial lung diseases.可能对进展性肺纤维化非特发性肺纤维化间质性肺疾病患者有抗纤维化药物的价值。
BMC Pulm Med. 2019 Nov 12;19(1):213. doi: 10.1186/s12890-019-0937-0.
10
Erratum to acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: a prospective study and review of the literature.《系统性风湿性疾病继发间质性肺疾病急性加重：一项前瞻性研究及文献综述》勘误
J Thorac Dis. 2020 Oct;12(10):6411. doi: 10.21037/jtd-2020-64.
本文引用的文献
1
Role of antifibrotic drugs in the management of post-COVID-19 interstitial lung disease: A review of literature and report from an expert working group.抗纤维化药物在新冠后间质性肺病管理中的作用：文献综述及专家工作组报告
Lung India. 2022 Mar-Apr;39(2):177-186. doi: 10.4103/lungindia.lungindia_659_21.
Zotero 插件